STOCK TITAN

Argan (AGX) insider files Form 144; reports Jan 2026 sales and Dec 2024 grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Argan, Inc. (AGX) affiliate submitted a Form 144 notice regarding proposed transactions in Common Stock. The filing lists prior grants including 2,592 shares (time-based restricted stock, 12/14/2024) and 6,964 shares (equity grant, 12/20/2024). It also records sales of 2,700 shares on 01/20/2026 and 5,000 shares on 01/27/2026 with proceeds shown in the filing.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of affiliate stock transactions; filings are routine notices.

The record lists compensation-related issuances (time-based restricted stock and equity grant) dated 12/14/2024 and 12/20/2024. It also shows two sales by John R. Jeffrey, Jr.: 2,700 shares on 01/20/2026 and 5,000 shares on 01/27/2026, with dollar amounts reported alongside each sale.

These notices document affiliate liquidity activity rather than operational results; cash‑flow treatment is indicated by the listed proceeds in the sale rows. Subsequent SEC filings may show whether additional planned sales proceed under the Form 144 notice.

Time-Based Restricted Stock Issuance 2,592 shares dated <date>12/14/2024</date>
Equity Grant 6,964 shares dated <date>12/20/2024</date>
Sale by John R. Jeffrey, Jr. 2,700 shares sold on <date>01/20/2026</date>
Sale by John R. Jeffrey, Jr. 5,000 shares sold on <date>01/27/2026</date>
Proceeds from 01/20/2026 sale $1,027,620 listed adjacent to the 2,700-share sale
Proceeds from 01/27/2026 sale $1,803,900 listed adjacent to the 5,000-share sale
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Time-Based Restricted Stock Issuance financial
"Common Stock | 12/14/2024 | Time-Based Restricted Stock Issuance"
Equity Grant financial
"Common Stock | 12/20/2024 | EQUITY GRANT"
Option Exercise financial
"12/20/2024 | OPTION EXERCISE"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AGX's Form 144 report?

It reports proposed and recent affiliate transactions in AGX common stock. The filing lists grants of 2,592 and 6,964 shares and two sales of 2,700 and 5,000 shares in January 2026.

Who is the selling party in the AGX Form 144?

The filing identifies John R. Jeffrey, Jr. as the reporting person. The rows show his sales of 2,700 and 5,000 shares on 01/20/2026 and 01/27/2026, respectively.

Do the Form 144 entries show sale proceeds for AGX transactions?

Yes; the sale rows include dollar figures next to the share sales. For example, the 2,700-share sale shows $1,027,620 and the 5,000-share sale shows $1,803,900 in the filing.